Changes in Staphylococcus aureus susceptibility across Latin America between 2004 and 2010

Brazilian Journal of Infectious Diseases

Volumn 17, Issue 1, 2013, Pages 13-19

  Garza González, Elvira ^a   Dowzicky, Michael Joseph ^b  

^a Medicina UANL   (Mexico)

^b PFIZER INC   (United States)

Author keywords

Antimicrobial surveillance; Latin America; Staphylococcus aureus; Tigecycline

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CEFTRIAXONE; IMIPENEM; LEVOFLOXACIN; LINEZOLID; MEROPENEM; METICILLIN; MINOCYCLINE; PENICILLIN DERIVATIVE; PIPERACILLIN PLUS TAZOBACTAM; TIGECYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARGENTINA; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BROTH DILUTION; CLINICAL RESEARCH; COLOMBIA; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MEXICO; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PUERTO RICO; SOUTH AND CENTRAL AMERICA;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; HUMANS; LATIN AMERICA; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; POPULATION SURVEILLANCE; STAPHYLOCOCCUS AUREUS;

EID: 84873154771     PISSN: 14138670     EISSN: 16784391     Source Type: Journal    
DOI: 10.1016/j.bjid.2012.08.017     Document Type: Article

References (25)

1. Monecke S., Coombs G., Shore A.C., et al. A field guide to pandemic, epidemic and sporadic clones of methicillin-resistant Staphylococcus aureus. PLoS ONE 2011, 6:e17936.
2. Stefani S., Goglio A. Methicillin-resistant Staphylococcus aureus: related infections and antibiotic resistance. Int J Infect Dis 2010, 14(Suppl. 4):S19-S22.
3. de Kraker M.E., Wolkewitz M., Davey P.G., Grundmann H. Clinical impact of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay related to methicillin-resistant Staphylococcus aureus bloodstream infections. Antimicrob Agents Chemother 2011, 55:1598-1605. BURDEN Study Group.
4. McKinnon P.S., Boening A.J., Amin A.N. Optimizing delivery of care for patients with MRSA infection: focus on transitions of care. Hosp Pract (Minneap) 2011, 39:18-31.
5. Guzmán-Blanco M., Mejía C., Isturiz R., et al. Epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) in Latin America. Int J Antimicrob Agents 2009, 34:304-308.
6. Mejía C., Zurita J., Guzmán-Blanco M. Epidemiology and surveillance of methicillin-resistant Staphylococcus aureus in Latin America. Braz J Infect Dis 2010, 14(Suppl. 2):S79-S86.
7. Rossi F., García P., Ronzon B., Curcio D., Dowzicky M.J. Rates of antimicrobial resistance in Latin America (2004-2007) and in vitro activity of the glycylcycline tigecycline and of other antibiotics. Braz J Infect Dis 2008, 12:405-415.
8. Clinical Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard - 8th edition. Document M7-A8. Wayne, PA: CLSI; 2009.
9. Clinical Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Twenty-First Informational Supplement. CLSI Document M100-S21. Wayne, PA: CLSI; 2011.
10. Johnson A.P. Methicillin-resistant Staphylococcus aureus: the European landscape. J Antimicrob Chemother 2011, 66(Suppl. 4):iv43-iv48.
11. Picao R., Sader H., Jones R., Andrade S., Gales A. Analysis of resistance and vancomycin " reverse creep" in Latin American Staphylococcus aureus: ten-year report of the SENTRY Antimicrobial Surveillance Program (1997-2006). Clin Microbiol Infect 2008, 14:S173.
12. Reyes J., Rincón S., Díaz L., et al. Dissemination of methicillin-resistant Staphylococcus aureus USA300 sequence type 8 lineage in Latin America. Clin Infect Dis 2009, 49:1861-1867.
13. Gales A.C., Jones R.N., Andrade S.S., Pereira A.S., Sader H.S. In vitro activity of tigecycline, a new glycylcycline, tested against 1,326 clinical bacterial strains isolated from Latin America. Braz J Infect Dis 2005, 9:348-356.
14. Sader H.S., Jones R.N., Gales A.C., et al. SENTRY antimicrobial surveillance program report: Latin American and Brazilian results for 1997 through 2001. Braz J Infect Dis 2004, 8:25-79.
15. Fernández Canigia L., Kaufman S., Lanata L., et al. Multicenter study to assess the in vitro activity of tigecycline by disk diffusion test against clinical isolates from Argentina. Chemotherapy 2009, 55:20-27.
16. Casellas J.M., Bantar C., Duret F. Comparative in vitro activity of tigecycline against aerobic and facultative isolates recovered from hospitalized patients: an Argentinean multicenter study. J Chemother 2007, 19:482-487. Argentinean Collaborative Test Group.
17. Silva-Sanchez J., Reyna-Flores F., Velazquez-Meza M.E., et al. In vitro activity of tigecycline against extended-spectrum β-lactamase-producing Enterobacteriaceae and MRSA clinical isolates from Mexico: a multicentric study. Diagn Microbiol Infect Dis 2011, 70:270-273.
18. Jones R.N., Ross J.E., Bell J.M., et al. Zyvox Annual Appraisal of Potency and Spectrum program: linezolid surveillance program results for 2008. Diagn Microbiol Infect Dis 2009, 65:404-413.
19. Luna C.M., Rodríguez-Noriega E., Bavestrello L., Gotuzzo E. Treatment of methicillin-resistant Staphylococcus aureus in Latin America. Braz J Infect Dis 2010, 14(Suppl. 2):S119-S127.
20. Oliveira G.A., Dell'Aquila A.M., Masiero R.L., et al. Isolation in Brazil of nosocomial Staphylococcus aureus with reduced susceptibility to vancomycin. Infect Control Hosp Epidemiol 2001, 22:443-448.
21. Palazzo I.C., Araujo M.L., Darini A.L. First report of vancomycin-resistant staphylococci isolated from healthy carriers in Brazil. J Clin Microbiol 2005, 43:179-185.
22. Delgado A., Riordan J.T., Lamichhane-Khadka R., et al. Hetero-vancomycin-intermediate methicillin-resistant Staphylococcus aureus isolate from a medical center in Las Cruces, New Mexico. J Clin Microbiol 2007, 45:1325-1329.
23. Otth R.L., Wilson S.M., Bustamante H.N., Fernández J.H., Otth L.C. Antimicrobial susceptibility and resistance patterns of Staphylococcus aureus isolated from patients and carriers in Valdivia city, Chile. Rev Chilena Infectol 2008, 25:175-178.
24. Sola C., Lamberghini R.O., Ciarlantini M., et al. Heterogeneous vancomycin-intermediate susceptibility in a community-associated methicillin-resistant Staphylococcus aureus epidemic clone, in a case of Infective Endocarditis in Argentina. Ann Clin Microbiol Antimicrob 2011, 10:15.
25. Bax R., Bywater R., Cornaglia G., et al. Surveillance of antimicrobial resistance-what, how and whither?. Clin Microbiol Infect 2001, 7:316-325.